OPTN OptiNose, Inc.

OptiNose Inc is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists.

As of 12/06/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  10/13/2017
Outstanding shares:  82,199,567
Average volume:  885,147
Market cap:   $129,053,320
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68404V100
ISIN:        US68404V1008
Valuation   (See tab for details)
PE ratio:   -1.42
PB ratio:   12.19
PS ratio:   1.88
Return on equity:   175.90%
Net income %:   -132.19%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy